We develop innovative solutions based on the analysis of exhaled biomarkers as useful tools for the diagnosis, prognosis, and monitoring of various respiratory diseases, among which asthma stands out. We currently have the evernoa BASE device, which allows to measure airway inflammation by detecting Nitric Oxide through a simple and non-invasive test.
Company’s Keywords:
id, biomarcadores exhalados, oxido nitrico, fabricacion, comercializacion, iso13485, dispositivos medicos, patentes, ehealth, r, d, exhaled biomarkers, nitric oxide, manufacturing, commercialization, medical devices, patents, feno, asthma diagnostic & management
<9
<
<2015
Your request has been submitted successfully.
Own or work here?